PEOPLE - HealthSouth (US) makes appointment:
This article was originally published in Clinica
HealthSouth, the diagnostic imaging firm based in Birmingham, Alabama, has made more management changes (see Clinica No 1114, p 19). Robert May, former acting CEO, has been named chairman of the board. He succeeds Joel Gordon, the firm's largest individual shareholder, who served as interim chairman until the company's turnaround in the wake of accounting investigations (see Clinica No 1089, p 12). Charles Elson has also joined the board of directors, effective September 1. He has served as an advisor to the board's governance committee since January 2003.
You may also be interested in...
Amarin had argued that Vascepa’s sales success showed that its patents were not obvious, but the court found otherwise, even as it concluded that Hikma, Dr. Reddy's and West-Ward has infringed on the fish oil pill's patents.
Grail announced results from an initial validation study that showed its early-detection blood test could identify 12 of the deadliest cancers with a low rate of false-positive results.
Shanghai Henlius Biotech has announced that China’s NMPA has accepted the firm’s filing for its HLX14 denosumab biosimilar. Meanwhile, the company has also announced dosing the first patient in a Phase II clinical trial of its novel HLX10 anti-PD-1 monoclonal antibody.